Home
ACRV
ACRV News

Latest Acrivon Therapeutics Inc. (ACRV) News on July 27, 2024

Is Acrivon Therapeutics, Inc. (ACRV) Stock Outpacing Its Medical Peers This Year?

Zacks

a month ago

Is Acrivon Therapeutics, Inc. (ACRV) Stock Outpacing Its Medical Peers This Year?

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

GuruFocus.com

a month ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

Energy Global

a month ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

USA TODAY

a month ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Business Wire

a month ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Business Wire

a month ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

SEALSQ to Launch Two New Quantum Resistant Chips

GlobeNewswire

a month ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Reuters

a month ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

GlobeNewswire

a month ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Is Acrivon Therapeutics, Inc. (ACRV) Outperforming Other Medical Stocks This Year?

Zacks

2 months ago

Is Acrivon Therapeutics, Inc. (ACRV) Outperforming Other Medical Stocks This Year?

Acrivon Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

2 months ago

Acrivon Therapeutics to Present at the Jefferies Global Healthcare Conference

Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock

Zacks

2 months ago

Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock

5 Small Drug Stocks to Buy From a Recovering Industry

Zacks

2 months ago

5 Small Drug Stocks to Buy From a Recovering Industry

Has Acrivon Therapeutics, Inc. (ACRV) Outpaced Other Medical Stocks This Year?

Zacks

2 months ago

Has Acrivon Therapeutics, Inc. (ACRV) Outpaced Other Medical Stocks This Year?

Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

2 months ago

Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Is a Surprise Coming for Acrivon Therapeutics (ACRV) This Earnings Season?

Zacks

3 months ago

Is a Surprise Coming for Acrivon Therapeutics (ACRV) This Earnings Season?

While institutions own 26% of Acrivon Therapeutics, Inc. (NASDAQ:ACRV), private equity firms are its largest shareholders with 50% ownership

Simply Wall St.

3 months ago

While institutions own 26% of Acrivon Therapeutics, Inc. (NASDAQ:ACRV), private equity firms are its largest shareholders with 50% ownership

MT Newswires

3 months ago

Ladenburg Thalmann Downgrades Acrivon Therapeutics to Neutral

Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event

GlobeNewswire

3 months ago

Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event

Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316

GlobeNewswire

3 months ago

Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316

Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resistance Mechanisms to ACR-368

GlobeNewswire

4 months ago

Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resistance Mechanisms to ACR-368

Acrivon Therapeutics Announces $130 Million Private Placement Financing

GlobeNewswire

4 months ago

Acrivon Therapeutics Announces $130 Million Private Placement Financing

GuruFocus.com

4 months ago

Acrivon Therapeutics Inc (ACRV) Reports Increased Annual Loss: A Detailed Look Against Analyst ...

Acrivon Therapeutics (NASDAQ:ACRV) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

4 months ago

Acrivon Therapeutics (NASDAQ:ACRV) Is In A Good Position To Deliver On Growth Plans

Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

GlobeNewswire

4 months ago

Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Acrivon Therapeutics to Present Data at AACR Annual Meeting Demonstrating Power of Acrivon Predictive Precision Proteomics (AP3) Platform and its Internally-Discovered, Potent WEE1/PKMYT1 Development Candidate, ACR-2316

GlobeNewswire

5 months ago

Acrivon Therapeutics to Present Data at AACR Annual Meeting Demonstrating Power of Acrivon Predictive Precision Proteomics (AP3) Platform and its Internally-Discovered, Potent WEE1/PKMYT1 Development Candidate, ACR-2316

Acrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA, Experienced Board Member and Healthcare Investor, to its Board of Directors

GlobeNewswire

5 months ago

Acrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA, Experienced Board Member and Healthcare Investor, to its Board of Directors

Acrivon Therapeutics to Participate in a Panel Discussion at the TD Cowen 44th Annual Health Care Conference

GlobeNewswire

5 months ago

Acrivon Therapeutics to Participate in a Panel Discussion at the TD Cowen 44th Annual Health Care Conference

Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovčević-Liebisch, Ph.D., J.D., to Board of Directors

GlobeNewswire

6 months ago

Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovčević-Liebisch, Ph.D., J.D., to Board of Directors

Acrivon Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire

6 months ago

Acrivon Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Quest Resource Holding Corporation's (NASDAQ:QRHC) top owners are retail investors with 36% stake, while 21% is held by institutions

Simply Wall St.

6 months ago

Quest Resource Holding Corporation's (NASDAQ:QRHC) top owners are retail investors with 36% stake, while 21% is held by institutions

Canopy Growth to Report Third Quarter Fiscal 2024 Financial Results on February 9, 2024

CNW Group

6 months ago

Canopy Growth to Report Third Quarter Fiscal 2024 Financial Results on February 9, 2024

NextNav Announces Appointment of John Muleta to Board of Directors

GlobeNewswire

6 months ago

NextNav Announces Appointment of John Muleta to Board of Directors

FingerMotion Provides Supplemental Quarterly Guidance

ACCESSWIRE

6 months ago

FingerMotion Provides Supplemental Quarterly Guidance

Zentek Announces Eric Wallman Appointed as Chairman of the Board

ACCESSWIRE

6 months ago

Zentek Announces Eric Wallman Appointed as Chairman of the Board

Franklin Street Properties Corp. Announces Tax Composition of 2023 Distributions

Business Wire

6 months ago

Franklin Street Properties Corp. Announces Tax Composition of 2023 Distributions

Mary Beth DeLena Joins PepGen as General Counsel and Secretary

GlobeNewswire

6 months ago

Mary Beth DeLena Joins PepGen as General Counsel and Secretary

Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Are Medical Stocks Lagging Amarin (AMRN) This Year?

Zacks

6 months ago

Are Medical Stocks Lagging Amarin (AMRN) This Year?

Senior Vice President David Knutson Sells 20,000 Shares of NextNav Inc

GuruFocus.com

6 months ago

Senior Vice President David Knutson Sells 20,000 Shares of NextNav Inc

Industrial Logistics Properties Trust Announces Quarterly Dividend on Common Shares

Business Wire

6 months ago

Industrial Logistics Properties Trust Announces Quarterly Dividend on Common Shares

Seanergy Maritime Holdings Corp (SHIP) is a Great Momentum Stock: Should You Buy?

Zacks

7 months ago

Seanergy Maritime Holdings Corp (SHIP) is a Great Momentum Stock: Should You Buy?

Tilly's (TLYS) Posts Soft Holiday Sales, Comps Decline 9%

Zacks

7 months ago

Tilly's (TLYS) Posts Soft Holiday Sales, Comps Decline 9%

RED ROBIN UNLEASHES FAMOUS GOURMET BURGERS, BREWS AND FUN AT NEWEST LOCATION IN ROSSFORD, OHIO

PR Newswire

7 months ago

RED ROBIN UNLEASHES FAMOUS GOURMET BURGERS, BREWS AND FUN AT NEWEST LOCATION IN ROSSFORD, OHIO

Monthly information on share capital and company voting rights

GlobeNewswire

7 months ago

Monthly information on share capital and company voting rights

New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program

Business Wire

7 months ago

New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program

Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Acrivon Therapeutics Appoints Jean-Marie Cuillerot, M.D., as Chief Medical Officer

GlobeNewswire

7 months ago

Acrivon Therapeutics Appoints Jean-Marie Cuillerot, M.D., as Chief Medical Officer

NaaS Technology Inc. Announces Amendment of Share Incentive Plan

PR Newswire

7 months ago

NaaS Technology Inc. Announces Amendment of Share Incentive Plan

Butterfly Network Announces Commercial Agreement with Mendaera for Next-Generation Interventional Robotic System Powered by Butterfly's Ultrasound-on-Chip™ Technology

Business Wire

7 months ago

Butterfly Network Announces Commercial Agreement with Mendaera for Next-Generation Interventional Robotic System Powered by Butterfly's Ultrasound-on-Chip™ Technology

Nature Wood Group Limited Announces First Half 2023 Unaudited Financial Results

PR Newswire

7 months ago

Nature Wood Group Limited Announces First Half 2023 Unaudited Financial Results

System1 to Participate in the 2024 ICR Conference

Business Wire

7 months ago

System1 to Participate in the 2024 ICR Conference

One G. Willi-Food International Insider Raised Stake By 15% In Previous Year

Simply Wall St.

7 months ago

One G. Willi-Food International Insider Raised Stake By 15% In Previous Year

GlobeNewswire

7 months ago

Gencor Releases Fourth Quarter and Fiscal Year 2023 Results

Will Qurate Retail (QRTEA) Benefit from “Project Athens”?

Insider Monkey

7 months ago

Will Qurate Retail (QRTEA) Benefit from “Project Athens”?

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

GlobeNewswire

8 months ago

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

NextNav Announces CEO Transition

GlobeNewswire

8 months ago

NextNav Announces CEO Transition

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Ovarian Cancer

GlobeNewswire

8 months ago

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Ovarian Cancer

Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Acrivon Therapeutics to Present at the Piper Sandler Annual Healthcare Conference

GlobeNewswire

8 months ago

Acrivon Therapeutics to Present at the Piper Sandler Annual Healthcare Conference

Markforged Receives Continued Listing Standards Notice from the NYSE

Business Wire

8 months ago

Markforged Receives Continued Listing Standards Notice from the NYSE

Geospace Technologies Corporation's (NASDAQ:GEOS) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Simply Wall St.

8 months ago

Geospace Technologies Corporation's (NASDAQ:GEOS) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

TH International Limited (NASDAQ:THCH) Screens Well But There Might Be A Catch

Simply Wall St.

8 months ago

TH International Limited (NASDAQ:THCH) Screens Well But There Might Be A Catch

Gabelli Global Small and Mid Cap Value Trust Declares Fourth Quarter Distribution of $0.16 Per Share

GlobeNewswire

8 months ago

Gabelli Global Small and Mid Cap Value Trust Declares Fourth Quarter Distribution of $0.16 Per Share

Gabelli Funds and Columbia Business School to Host 5th Annual Healthcare Symposium

GlobeNewswire

8 months ago

Gabelli Funds and Columbia Business School to Host 5th Annual Healthcare Symposium

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Xtant Medical Holdings Inc Earnings Call

Xtant Medical to Participate in Upcoming Investor Conferences

GlobeNewswire

9 months ago

Xtant Medical to Participate in Upcoming Investor Conferences

Acrivon Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights

GlobeNewswire

9 months ago

Acrivon Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights

Alto Ingredients, Inc. to Participate in Upcoming Conferences

GlobeNewswire

9 months ago

Alto Ingredients, Inc. to Participate in Upcoming Conferences

Associated Press Finance

9 months ago

Performant Financial: Q3 Earnings Snapshot

Performant Financial Corporation Announces Financial Results for Third Quarter 2023

Business Wire

9 months ago

Performant Financial Corporation Announces Financial Results for Third Quarter 2023

Owning 49% shares,institutional owners seem interested in Performant Financial Corporation (NASDAQ:PFMT),

Simply Wall St.

9 months ago

Owning 49% shares,institutional owners seem interested in Performant Financial Corporation (NASDAQ:PFMT),

Performant Financial Corporation Announces Completion of Debt Refinancing

Business Wire

9 months ago

Performant Financial Corporation Announces Completion of Debt Refinancing

Share on Social Networks: